Cord Blood Transplantation for Patients With Cancer
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the rate of engraftment with combined
haploidentical-cord blood transplantation in patients with pre-existing donor specific
antibodies and in those with active disease.